SAPHRA approves Pfizer vaccine for children aged 12 and over
The South African Health Products Regulatory Authority has approved the use of the Pfizer–BioNTech COVID-19 vaccine in children aged 12 and above, following a review of updated safety and efficacy data.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthSAPHRA approves Pfizer vaccine for children aged 12 and over
Sign in or subscribeBrowse free archive reportsThe South African Health Products Regulatory Authority has approved the use of the Pfizer–BioNTech COVID-19 vaccine in children aged 12 and above, following a review of updated safety and efficacy data.